Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure

OBJECTIVE: Although vasodilators are used in acute heart failure (AHF) management, there have been no clear supportive evidence regarding their routine use. Recent European guidelines recommend systolic blood pressure (SBP) reduction in the range of 25% during the first few hours after diagnosis. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Heart
Main Authors: Kitai, Takeshi, Tang, W H Wilson, Xanthopoulos, Andrew, Murai, Ryosuke, Yamane, Takafumi, Kim, Kitae, Oishi, Shogo, Akiyama, Eiichi, Suzuki, Satoshi, Yamamoto, Masayoshi, Kida, Keisuke, Okumura, Takahiro, Kaji, Shuichiro, Furukawa, Yutaka, Matsue, Yuya
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Heart Failure and Cardiomyopathies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6045748/
https://ncbi.nlm.nih.gov/pubmed/30018782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2018-000845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados